THE HOUSE OF SHANN CHRISTEN
THE CONSERVATORY PAPERS
Paper No. 176
The Man, the Follicle & the Passage of Time
Male-Pattern Hair Loss, DHT, Regrowth, and the Future of Trichological Care
Scientific Classification: Androgenetic Alopecia • DHT • Follicular Miniaturization • Chronobiology • Regenerative Research Conservatory Classification: Men • Preservation • Regrowth • Treatment • Evidence
Opening Manuscript — The Pattern That Appears Over Time
A man may first notice a retreating temple, a widening forehead, or light passing through the hair at his crown. Male-pattern hair loss often arrives gradually, not as a single dramatic shedding event.
The follicle may remain present while producing increasingly finer, shorter hairs. The visible loss is therefore not merely a question of hairs falling. It is also a question of what each follicle can produce in its next growth cycle.
The House begins with that distinction.
The Biology — DHT and the Susceptible Follicle
The enzyme 5-alpha-reductase converts testosterone into dihydrotestosterone (DHT). In genetically susceptible scalp follicles, androgen-receptor signaling contributes to progressive miniaturization. The anagen growth phase may shorten and terminal-hair caliber may decline.
DHT is not a toxin deposited in the follicle, and cleansing has not been shown to wash it away. The important question is how a particular follicle responds to androgen signaling, not simply whether testosterone is present.
The temples, frontal scalp, and vertex are commonly affected, while the occipital region may be relatively spared. The Norwood–Hamilton patterns describe visible distribution, not every biological detail.
Testosterone, Enhancement Products, and Risk
Prescribed testosterone, anabolic-androgenic steroids, and products marketed as hormone boosters deserve careful inquiry. Increased androgen exposure can aggravate patterned loss in susceptible individuals, but responses differ.
Many commercial “testosterone boosters” lack convincing evidence of hormonal efficacy, and their ingredients and safety vary. We should not assume that every such product raises DHT or accelerates balding.
A man considering or receiving hormone therapy should discuss hair changes with the prescribing clinician. Prescribed therapy should not be stopped independently. Nonmedical anabolic steroid use carries significant health risks beyond hair loss.
Shedding Is Not Miniaturization
Telogen effluvium shifts the timing of hair release, often following illness, rapid weight change, or another physiological disturbance. Androgenetic alopecia changes the caliber of hair produced by susceptible follicles over repeated cycles.
Both may occur together. Examination, history, and trichoscopy can help distinguish a sudden increase in club-hair shedding from shaft-diameter diversity and patterned miniaturization.
The treatment should follow the process identified.
DHT Reduction and the Challenge of Regrowth
Finasteride inhibits 5-alpha-reductase and has established evidence for slowing male-pattern hair loss and improving growth in some men. Minoxidil works through different mechanisms; it is not simply a DHT blocker and can improve hair growth in selected patients.
Preserving existing density and recovering terminal-hair caliber are different objectives. Neither therapy guarantees full recovery of longstanding bald areas. Benefits vary, require months to evaluate, and often depend on continued treatment.
Other clinician-directed options, including selected use of dutasteride, oral minoxidil, or transplantation, require individual assessment of evidence, safety, and suitability.
Mario Zunino, Esterel, and the BioMethod Tradition
Mario Zunino's Esterel approach emphasized scalp observation and a sequenced regimen. The House's historical use of the 5-Alpha ampoule, Action Pro Capillaire, and Fortifiant ampoule reflects distinct intended roles: androgen-related care, stimulation and support of hair growth, and continuing care of the emerging fiber and scalp.
This professional heritage deserves careful preservation. Yet product-specific claims that these ampoules block follicular DHT, activate keratinocytes, or restore miniaturized hairs to full terminal caliber require controlled evidence demonstrating those outcomes. Intended actions and practitioner observations are not the same as established clinical efficacy.
Comprehensive care is valuable when its components answer different, demonstrable needs. It should not be represented as proof that combining products necessarily produces superior regrowth.
Sweat, Sebum, and the Exposed Scalp
With reduced hair density, perspiration, oiliness, scale, and scalp shine may become more visible. The scalp can also receive greater sun exposure.
Sweat and sebum are normal physiology. Their visibility does not prove that they have increased or that they accelerate androgenetic alopecia. Seborrheic dermatitis and other inflammatory conditions may coexist and deserve appropriate treatment.
Cleansing can remove surface material and improve comfort. It does not remove DHT from follicular tissue or, by itself, reverse genetic miniaturization.
Chronobiology — A Fifteen-Week Discipline
Hair cycles through anagen, catagen, telogen, and exogen. Meaningful changes in density often take months to assess.
The House's traditional fifteen-week sequence culminating near the spring and autumn equinoxes can provide a disciplined period of observation and continuity. Human hair cycling shows some seasonal variation, but controlled evidence has not established that equinox-timed treatment improves outcomes over other schedules.
The calendar organizes our care. It does not command the follicle.
Peptides and Emerging Regenerative Science
Research into signaling peptides, dermal papilla activity, keratinocytes, and follicular stem-cell biology is expanding the possibilities for future treatment.
Specific peptides have shown encouraging findings in laboratory studies and some small human investigations, but these findings cannot be generalized to every peptide formulation. Laboratory stimulation of a pathway is not equivalent to durable regrowth of terminal hair in people.
Investigational approaches targeting dormant follicular stem cells remain under clinical study. They should be distinguished from approved, evidence-based treatments.
The House can welcome scientific possibility without promising that possibility has already become clinical certainty.
The Discipline of Inquiry
A thoughtful assessment begins with the rate and pattern of loss, family history, scalp examination, hair-shaft caliber, medication and hormone exposure, and possible coexisting shedding or inflammation.
The plan then distinguishes three goals: preserving existing hair, improving growth where follicles remain responsive, and caring for the scalp and existing fiber.
Each intervention should have a reason. Each claim should have evidence. Progress should be assessed with consistent observations over an appropriate interval.
The House Perspective — Preservation, Regeneration, and Time
After a lifetime devoted to the study of hair, I have come to understand that male-pattern baldness is not simply a matter of hair falling from the scalp.
It is a progressive change in the biological capacity of the follicle.
Androgen signaling, particularly the influence of DHT upon genetically susceptible follicles, can gradually alter the production of terminal hair. Over successive growth cycles, the follicle may produce a fiber that is shorter, finer, and less capable of contributing to visible density.
The question is not merely how to prevent another hair from falling.
It is whether the follicle retains the biological capacity to produce a stronger hair again.
This distinction has shaped my approach to trichology.
Through Mario Zunino's Esterel tradition, I learned to examine the scalp as a living environment requiring observation, cleansing, and appropriate care.
Through BioMethod, I continued developing the philosophy that the scalp, the follicle, and the hair fiber must each be understood according to their individual needs.
And through chronobiology, we recognize that the follicle is governed not only by chemistry, but also by time.
Its cycles cannot be rushed simply because we desire immediate results.
The Promise and Responsibility of Regenerative Science
Today, research into peptides, follicular signaling, dermal papilla activity, stem-cell regulation, and keratinocyte biology is opening important new questions about hair regeneration.
These developments are promising, but promise must not be confused with established clinical success.
A molecule that stimulates a cellular pathway in laboratory research has not necessarily demonstrated meaningful hair regrowth in humans.
Likewise, a treatment that improves scalp condition has not necessarily reversed follicular miniaturization.
Within the House, we must preserve the distinction between established treatment, emerging research, and the professional observations that have shaped our methods.
This is how we honor both scientific progress and the history of our craft.
The Wisdom of the Treatment Cycle
The House's traditional fifteen-week treatment rhythm reflects a philosophy of disciplined continuity.
Its relationship to the changing seasons and the spring and autumn equinoxes gives the program a meaningful structure.
But seasonal symbolism and documented variation in hair cycling should not be mistaken for proof that an equinox-timed regimen produces superior regrowth.
The biological effectiveness of any treatment must be evaluated through measurable outcomes, appropriate follow-up, and reliable evidence.
The purpose of continuity is not to impose a calendar upon nature.
It is to remain attentive while nature completes its work.
Closing Manuscript — The Follicle and the Future
The progressive loss of a man's hair is a biological process influenced by genetics, androgen signaling, follicular sensitivity, and time.
DHT-directed treatment may help preserve hair in appropriately selected individuals.
Evidence-based growth therapies may improve hair production in some miniaturized follicles.
Scalp care may address additional conditions affecting comfort, inflammation, and hair-fiber integrity.
And emerging regenerative science may eventually expand the possibilities available to us.
But these are distinct interventions, each deserving its own evidence and expectations.
The wisdom of trichology is not found in declaring that one product or one mechanism holds every answer.
It is found in recognizing what is changing, what may still be preserved, and which interventions have a reasonable opportunity to help.
Mario Zunino's influence taught me to respect the scalp.
My work with BioMethod taught me to respect the individuality of every treatment.
And the study of hair biology continues to teach me the importance of patience.
We cannot command the follicle to return to its past. But through understanding, we may help preserve and support its future.
— Shann Christen
Related Specimens
Paper No. 148 — Chronobiology: The Architecture of Time
Paper No. 172 — Differential Inquiry: The Question Before the Answer
Paper No. 173 — When the Hair Begins to Fall
Paper No. 174 — Female-Pattern Hair Loss
Paper No. 177 — The Man in the Mirror
Scientific References
American Academy of Dermatology Association. Hair Loss: Diagnosis and Treatment. https://www.aad.org/public/diseases/hair-loss/treatment/diagnosis-treat
Kaufman KD et al. Finasteride in the Treatment of Men with Androgenetic Alopecia. J Am Acad Dermatol. 1998;39:578–589. https://pubmed.ncbi.nlm.nih.gov/9777765/
Olsen EA et al. A Randomized Clinical Trial of 5% Topical Minoxidil versus 2% Topical Minoxidil and Placebo in Men with Androgenetic Alopecia. J Am Acad Dermatol. 2002;47:377–385. https://pubmed.ncbi.nlm.nih.gov/12196747/
Randall VA. Androgens and Hair Growth. Dermatol Ther. 2008;21:314–328. https://pubmed.ncbi.nlm.nih.gov/18844710/
House Principle
Biology before intervention. Preservation before correction. Understanding before recommendation.
Nature Perfected Through Science.